QA: Hospira INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001274057_2012_Hospira_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'0010 - Statement - Consolidated Statements of (Loss) Income and Comprehensive (Loss) Income': 13, '0011 - Statement - Consolidated Statements of Income and Comprehensive Income (Calc 2)': 7}}

Graph

Absolute values for 0001274057, Hospira INC

  xvar xval
0 AssetsCurrent 2,570,700,000
1 IntangibleAssetsNetIncludingGoodwill 1,438,700,000
2 PropertyPlantAndEquipmentNet 1,355,000,000
3 remainder_Assets 414,700,000
4 LiabilitiesCurrent 847,800,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 637,300,000
9 ResearchAndDevelopmentExpense 258,800,000
10 remainder_Expenses 3,225,200,000
11 remainder_Revenues 4,057,100,000
12 remainder_NetIncome 54,800,000
13 remainder_ComprehensiveNetIncome -140,600,000
  yvar yval
0 Assets 5,779,100,000
1 Liabilities 847,800,000
2 Expenses 4,121,300,000
3 Revenues 4,057,100,000
4 StockholdersEquity 4,931,300,000
5 NetIncome -9,400,000
6 ComprehensiveNetIncome -79,700,000
7 BaseVar 7,500,350,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.22
9 EconomicCapitalRatio 3.84

Edgar->Model Mapping

Feature Distribution

Change over Time